Cyclerion Therapeutics, Inc. — All Filings
337 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-053035 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-003509 | Jan 6, 2026 | Jan 3, 2026 |
| 8-K | 8-K | 0001193125-25-304067 | Dec 1, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-277749 | Nov 12, 2025 | Sep 30, 2025 |
| 10-K/A | 10-K/A | 0001193125-25-277621 | Nov 12, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | — | 0001493152-25-018450 | Oct 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-213332 | Sep 23, 2025 | Sep 19, 2025 |
| SCHEDULE 13G/A | — | 0001641172-25-024017 | Aug 14, 2025 | — |
| 4 | 4 | 0000950170-25-106532 | Aug 11, 2025 | Aug 7, 2025 |
| 10-Q | 10-Q | 0000950170-25-103123 | Aug 5, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001193125-25-142765 | Jun 18, 2025 | Jun 16, 2025 |
| EFFECT | — | 9999999995-25-001628 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-010930 | May 15, 2025 | — |
| CORRESP | — | 0001193125-25-118816 | May 13, 2025 | — |
| UPLOAD | — | 0000000000-25-005035 | May 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-115089 | May 7, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-115085 | May 7, 2025 | — |
| S-3 | S-3 | 0001193125-25-113869 | May 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-064493 | May 6, 2025 | Mar 31, 2025 |
| DEFA14A | DEFA 14A | 0001140361-25-016374 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-016370 | Apr 29, 2025 | Jun 16, 2025 |
| SCHEDULE 13D/A | — | 0000950170-25-047124 | Mar 28, 2025 | — |
| 4 | 4 | 0000950170-25-046280 | Mar 27, 2025 | Mar 25, 2025 |
| 4 | 4 | 0000950170-25-046099 | Mar 27, 2025 | Mar 25, 2025 |
| 8-K | 8-K | 0001193125-25-062612 | Mar 25, 2025 | Mar 21, 2025 |
| 10-K | 10-K | 0000950170-25-032037 | Mar 4, 2025 | Dec 31, 2024 |
| EFFECT | — | 9999999995-25-000427 | Feb 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-018782 | Feb 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-018622 | Feb 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000869 | Feb 12, 2025 | — |
| CORRESP | — | 0001193125-25-023605 | Feb 10, 2025 | — |
| UPLOAD | — | 0000000000-25-001353 | Feb 7, 2025 | — |
| S-3 | S-3 | 0001193125-25-020077 | Feb 4, 2025 | — |
| 8-K | 8-K | 0001193125-24-280125 | Dec 17, 2024 | Dec 13, 2024 |
| SCHEDULE 13G/A | — | 0000902664-24-006852 | Dec 6, 2024 | — |
| 4 | — | 0000902664-24-006775 | Nov 25, 2024 | Nov 21, 2024 |
| 10-Q | 10-Q | 0000950170-24-127116 | Nov 14, 2024 | Sep 30, 2024 |
| 4 | 4 | 0000950170-24-092733 | Aug 7, 2024 | Aug 5, 2024 |
| 8-K | 8-K | 0001193125-24-195410 | Aug 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-092257 | Aug 7, 2024 | Jun 30, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-178653 | Jul 12, 2024 | — |
| 8-K | 8-K | 0001193125-24-161591 | Jun 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-054602 | May 7, 2024 | Mar 31, 2024 |
| DEFA14A | DEFA14A | 0001140361-24-022986 | Apr 29, 2024 | — |
| DEF 14A | DEF 14A | 0001140361-24-022981 | Apr 29, 2024 | Jun 14, 2024 |
| 8-K | 8-K | 0001193125-24-100763 | Apr 18, 2024 | — |
| 3 | 3 | 0000950170-24-029219 | Mar 11, 2024 | Mar 4, 2024 |
| 10-K | 10-K | 0000950170-24-025935 | Mar 5, 2024 | Dec 31, 2023 |
| SC 13G/A | — | 0001493152-24-006650 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-030268 | Feb 9, 2024 | — |